RESPONSE RATES TO CARBOPLATIN AND PEMETREXED IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - A SINGLE CENTRE AUDIT

被引：0
|
作者：
Talbot, Toby L. J.
Collinson, Matthew P.
Buscombe, Charlotte
Pascoe, Susan
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Non-small cell lung cancer; Chemotherapy; Carboplatin; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1210 / S1210
页数：1
相关论文
共 50 条
  • [1] CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY
    Andersen, R.
    Mellemgaard, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S73
  • [2] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [3] MODALITY OF TISSUE BIOPSY AND MUTATIONAL ANALYSIS IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE AUDIT
    Moore, S.
    Murphy, M.
    Hukins, C.
    Loff, K.
    RESPIROLOGY, 2019, 24 : 160 - 160
  • [4] A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer
    Afzal, Muhammad Zubair
    Dragnev, Konstantin
    Shirai, Keisuke
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3575 - 3584
  • [5] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131
  • [6] Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
    Zhang, Liang
    Ou, Wei
    Liu, Qianwen
    Li, Ning
    Liu, Li
    Wang, Siyu
    THORACIC CANCER, 2014, 5 (01) : 50 - 56
  • [7] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [8] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A Phase I Study of Exemestane with Carboplatin and Pemetrexed in Postmenopausal Women with Metastatic, Non-Squamous Non-Small Cell Lung Cancer
    Pietras, Richard
    Goldman, Jonathan W.
    Marquez-Garban, Diana C.
    Wong, Deborah J. L.
    Applebaum, Steven
    Mendenhall, Melody
    Ledezma, Blanca A.
    Wolf, Brian
    Adame, Carlos R.
    Rosales, Sarah
    Paroly, Jill
    Paiz, Sebastian
    Nameth, Danielle
    Spiegel, Marshall L.
    Hecht, Naomi
    Brennan, Meghan
    Dubinett, Steven M.
    Garon, Edward B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [10] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
12345